Why did Corteva raise its 2026 full-year outlook despite lower second-quarter sales?

Corteva raised its 2026 full-year outlook due to first-half momentum, incremental benefits from controllable cost actions, and growth platforms; specifically, seed price/mix gains and higher royalty income helped offset continued pressure in crop protection, leading to stronger adjusted earnings and improved operating EBITDA performance.

What were the key financial updates Corteva provided for its 2026 full-year guidance?

Corteva updated its 2026 full-year guidance to expect operating EBITDA of $4.1 billion–$4.3 billion (up from $4.0 billion–$4.2 billion) and adjusted EPS of $3.60–$3.80 (up from $3.45–$3.70), citing first-half momentum, controllable cost actions, and growth platforms as drivers.

Corteva Raises 2026 Outlook as Seed Strength Offsets Crop Protection Pressure

Jul 31, 2026

Corteva raised its 2026 financial outlook citing seed segment strength that offset crop protection pressures, reporting higher adjusted EPS and EBITDA. The agtech firm confirmed plans to spin off its seeds business into Vylor by October 1.

chemweek

2026-06-12

Corteva Flags Higher Restructuring Charges, Plans Spain Site Exit

2026-07-30

Corteva raises full-year profit forecast, shares fall after revenue miss

2026-07-31

Corteva Raises 2026 Outlook as Seed Strength Offsets Crop Protection Pressure

2026-09-15

Corteva CEO Makes a Case for Crop Chemicals in the Age of MAHA

Corteva Raises 2026 Outlook as Seed Strength Offsets Crop Protection Pressure

FAQ